awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
Graphs
1
Q53389706-0C3FDC6D-08CF-476C-BFC6-03677C89648C
Q53389706-0C3FDC6D-08CF-476C-BFC6-03677C89648C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q53389706-0C3FDC6D-08CF-476C-BFC6-03677C89648C
A phase I/Ib study of trametinib (GSK1120212) alone and in combination with gemcitabine in Japanese patients with advanced solid tumors.
P2860
Q53389706-0C3FDC6D-08CF-476C-BFC6-03677C89648C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q53389706-0C3FDC6D-08CF-476C-BFC6-03677C89648C
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
96581c10fc211fecfeeee094cf3bf177ed21caca
P2860
Randomized phase III study of gemcitabine plus S-1, S-1 alone, or gemcitabine alone in patients with locally advanced and metastatic pancreatic cancer in Japan and Taiwan: GEST study.